- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bret Jackson on Congress' Attempt to Curb Surprise Medical Billing
Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.
Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.
What is your view on the bill in Congress to reduce healthcare costs and how it approaches surprise medical billing?
So, the debate in Washington is whether or not we’re going to have a Medicare-plus rate to reimburse on surprise bills, or are we going to go into arbitration. And, I think what arbitration does is really codify the practice of surprise billing, which is a way around provider agreements. Instead of patients being able to really see relief, while the bill may relieve the patients upfront, they’re going to get the [charges] in added premiums, increased deductibles, increased co-pays; so, ultimately, a patient is going to pay for a surprise bill.
We would rather see Congress act on policies that allow for a long-term, stable arrangement between providers and insurance companies, rather than have a system where an arbitrator picks one price versus the other.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Patient-Reported QOL Outcomes of Initial CLL Treatments: ASH 2024
January 8th 2025Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL), according to research presented at the 2024 American Society of Hematology (ASH) meeting.
Read More
